SCHEMBL3622901

SCHEMBL3622901

C=Cc1cccc2c1ccn2S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.58
UBE2N P61088 1/20 0.58
HTR6 P50406 13/20 0.53
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.47
CA2 P00918 2/20 0.44
CA9 Q16790 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4023676 0.93 KDM4E (0.51) KDM4EUBE2NHTR6HDAC3HDAC4
SCHEMBL29875473 0.88 KDM4E (0.71) KDM4EUBE2NHTR6HDAC3HDAC4
SCHEMBL1419196 0.88 KDM4E (0.71) KDM4EUBE2NHTR6HDAC3HDAC4
SCHEMBL3619658 0.87 HTR6 (0.62) HTR6HDAC3HDAC4HDAC1HDAC7
SCHEMBL3613863 0.86 HTR6 (0.53) KDM4EUBE2NHTR6HDAC3HDAC4
SCHEMBL14723388 0.83 KDM4E (0.54) KDM4EUBE2NHTR6HDAC3HDAC4
SCHEMBL14723387 0.83 KDM4E (0.54) KDM4EUBE2NHTR6HDAC3HDAC4
SCHEMBL16291995 0.82 KDM4E (0.80) KDM4EUBE2NHTR6L3MBTL1CA2
SCHEMBL31262899 0.82 KDM4E (0.80) KDM4EUBE2NHTR6L3MBTL1CA2
SCHEMBL4021608 0.82 HDAC3 (0.51) KDM4EUBE2NHTR6HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046741-B1 INDOLES AS 5-HT6 MODULATORS PROXIMAGEN LTD (GB) 2012-10-31 EP disclosed
US-7812017-B2 4-substituted indole and indoline compounds BIOVITRUM AB (PUBL.) (SE) 2010-10-12 US disclosed
EP-2046741-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (publ) (SE) 2009-04-15 EP disclosed
US-20080032968-A1 New compounds PROXIMAGEN NEUROSCIENCE PLC (GB) 2008-02-07 US disclosed
WO-2008003703-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (PUBL) (SE) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080032968-A1 New compounds HTR6, HTR1B, HTR1A KDM4E 3665/4885UBE2N 2141/4885HTR6 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.